Search Results - "Meerson, Mark"

Multifaceted deregulation of gene expression and protein synthesis with age by Anisimova, Aleksandra S., Meerson, Mark B., Gerashchenko, Maxim V., Kulakovskiy, Ivan V., Dmitriev, Sergey E., Gladyshev, Vadim N.

“…Protein synthesis represents a major metabolic activity of the cell. However, how it is affected by aging and how this in turn impacts cell function remains…”
Get full text

Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer’s Disease Platform by Karelina, Tatiana, Lerner, Stepan, Stepanov, Alexandr, Meerson, Mark, Demin, Oleg

“…For many years, clinical research in Alzheimer’s disease (AD) has focused on attempts to identify the most explicit biomarker, namely amyloid beta…”
Get full text

Protein encoded in human telomerase RNA is involved in cell protective pathways by Rubtsova, Maria, Naraykina, Yulia, Vasilkova, Daria, Meerson, Mark, Zvereva, Maria, Prassolov, Vladimir, Lazarev, Vasily, Manuvera, Valentin, Kovalchuk, Sergey, Anikanov, Nickolay, Butenko, Ivan, Pobeguts, Olga, Govorun, Vadim, Dontsova, Olga

“…Abstract Several studies have described functional peptides encoded in RNA that are considered to be noncoding. Telomerase RNA together with telomerase reverse…”
Get full text

Integrated Genomic and Transcriptomic Analysis Provides Molecular Characterization of Distinct Clonal Evolution Pathways during Follicular Lymphoma Transformation by Almog, Nava, Novokreshchenova, Anna, Smirnova, Sofia, Brown, Jessica H., Kotlov, Nikita, Meerson, Mark, Anosov, Ilya, Akpek, Gorgun, Ayrons, Keith, Fowler, Nathan H., Ferguson, Kevin

Get full text

Preliminary Analysis of an Ongoing Phase II Study of Response-Adapted Therapy with Copanlisib and Rituximab for Untreated Follicular Lymphoma by Lakhotia, Rahul, Melani, Christopher, Muppidi, Jagan R., Pittaluga, Stefania, Phelan, James D, Ramsower, Colleen, Rimsza, Lisa M., Robertorye, Ryan S, Wright, George, Meerson, Mark, Postovalova, Ekaterina, Bagaev, Alexander, Fowler, Nathan, Lindenberg, Liza, Mena, Esther, Bergvall, Ethan, Pradhan, Amynah, Tadese, Atekelt, Morrison, Candis, Evans, Sarah, Berg, Sumaya, Steinberg, Seth M., Figg, William, Jaffe, Elaine S., Staudt, Louis M., Wilson, Wyndham H., Roschewski, Mark

“…Introduction Frontline therapy for pts with follicular lymphoma (FL) is not based on the molecular profile of the tumor. The PI3K pathway is central to FL…”
Get full text

Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients by Radtke, Andrea J, Postovalova, Ekaterina, Varlamova, Arina, Bagaev, Alexander, Sorokina, Maria, Kudryashova, Olga, Meerson, Mark, Polyakova, Margarita, Galkin, Ilia, Svekolkin, Viktor, Isaev, Sergey, Wiebe, Daniil, Sharun, Anna, Sarachakov, Alexander, Perelman, Grigory, Lozinsky, Yaroslav, Yaniv, Ziv, Lowekamp, Bradley C, Speranza, Emily, Yao, Li, Pittaluga, Stefania, Shaffer, 3rd, Arthur L, Jonigk, Danny, Phelan, James D, Davies-Hill, Theresa, Huang, Da Wei, Ovcharov, Pavel, Nomie, Krystle, Nuzhdina, Ekaterina, Kotlov, Nikita, Ataullakhanov, Ravshan, Fowler, Nathan, Kelly, Michael, Muppidi, Jagan, Davis, Jeremy L, Hernandez, Jonathan M, Wilson, Wyndham H, Jaffe, Elaine S, Staudt, Louis M, Roschewski, Mark, Germain, Ronald N

“…Follicular lymphoma (FL) is a generally incurable malignancy that evolves from developmentally blocked germinal center (GC) B cells. To promote survival and…”
Get more information

A Prospective Study of Clonal Evolution in Follicular Lymphoma: Circulating Tumor DNA Correlates with Overall Tumor Burden and Fluctuates over Time without Therapy by Distler, Allison, Lakhotia, Rahul, Phelan, James D., Pittaluga, Stefania, Melani, Christopher, Muppidi, Jagan R., Simard, Jillian, Pradhan, Amynah, Hillsman, Amy, Yang, Yandan, Davies-Hill, Theresa, Shaffer, Arthur L., Evans, Sarah, Ahlman, Mark A., Jacob, Allison P., Bagaev, Alexander, Meerson, Mark, Postovalova, Ekaterina, Kudryashova, Olga, Kotlov, Nikita, Fowler, Nathan H., Jaffe, Elaine S., Staudt, Louis M., Wilson, Wyndham H., Roschewski, Mark

“…Background: Follicular lymphoma (FL) shows marked variation in clinical course including spontaneous regression and histologic transformation (HT). Watchful…”
Get full text

Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib by Roschewski, Mark, Phelan, James D., Pittaluga, Stefania, Melani, Christopher, Lakhotia, Rahul, Chabon, Jacob J., Muppidi, Jagan R., Lurain, Kathryn A., Simard, Jillian, Pradhan, Amynah, Hillsman, Amy, Rilko, Madeline, Steinberg, Seth M., Wright, George W., Huang, Da Wei, Yang, Yandan, Lionakis, Michail S., Bagaev, Alexander, Postovalova, Ekaterina, Meerson, Mark, Kudryashova, Olga, Kotlov, Nikita, Fowler, Nathan H., Kurtz, David M., Alizadeh, Ash A., Jaffe, Elaine S., Staudt, Louis M., Wilson, Wyndham H.

“…Background: Diffuse large B-cell lymphoma (DLBCL) subtypes have differential response to BTK inhibitors (BTKi). Ibrutinib with R-CHOP improves survival in…”
Get full text

Integration and Iteration: Using Advanced, High-Content Imaging and Single-Cell Gene Expression Analysis to Uncover Unique Aspects of Follicular Lymphoma Biology by Radtke, Andrea J., Shaffer, Arthur L., Pittaluga, Stefania, Bagaev, Alexander, Thakur, Nishant, Davies-Hill, Theresa, Plotnikova, Olga, Galkin, Ilia, Postovalova, Ekaterina, Svekolkin, Viktor, Isaev, Sergei, Lozinsky, Yaroslav, Meerson, Mark, Varlamova, Arina, Ovcharov, Pavel, Polyakova, Margarita, Nomie, Krystle, Nuzhdina, Ekaterina, Kotlov, Nikita, Tsiper, Maria, Frenkel, Felix, Attaulakhanov, Ravshan, Fowler, Nathan H, Yaniv, Ziv, Lowekamp, Bradley C, Kelly, Michael, Dadkhah, Ezzat, Huang, Da Wei, Muppidi, Jagan R., Jaffe, Elaine S., Wilson, Wyndham H., Staudt, Louis M., Germain, Ronald N., Roschewski, Mark

“…BACKGROUND: Follicular lymphoma (FL) is an indolent malignancy of germinal center B-cell origin. FL patients experience remarkable heterogeneity in their…”
Get full text

Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression by Han, Guangchun, Deng, Qing, Marques-Piubelli, Mario L, Dai, Enyu, Dang, Minghao, Ma, Man Chun John, Li, Xubin, Yang, Haopeng, Henderson, Jared, Kudryashova, Olga, Meerson, Mark, Isaev, Sergey, Kotlov, Nikita, Nomie, Krystle J, Bagaev, Alexander, Parra, Edwin R, Solis Soto, Luisa M, Parmar, Simrit, Hagemeister, Fredrick B, Ahmed, Sairah, Iyer, Swaminathan P, Samaniego, Felipe, Steiner, Raphael, Fayad, Luis, Lee, Hun, Fowler, Nathan H, Flowers, Christopher R, Strati, Paolo, Westin, Jason R, Neelapu, Sattva S, Nastoupil, Loretta J, Vega, Francisco, Wang, Linghua, Green, Michael R

“…Follicular lymphoma (FL) is a B-cell malignancy with a complex tumor microenvironment that is rich in nonmalignant immune cells. We applied single-cell RNA…”
Get full text